id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-2046-0003,FDA,FDA-2020-E-2046,Letter to U S Patent and Trademark Office,Other,Letter(s),2020-12-14T05:00:00Z,2020,12,2020-12-14T05:00:00Z,,2020-12-14T15:34:06Z,,0,0,090000648499c79a
FDA-2020-E-2046-0002,FDA,FDA-2020-E-2046,Patent Term Extension Application for NEXLETOL,Other,Application,2020-10-02T04:00:00Z,2020,10,2020-10-02T04:00:00Z,,2020-10-02T21:47:15Z,,0,0,09000064848b8f84
FDA-2020-E-2046-0001,FDA,FDA-2020-E-2046,Letter from the U S Patent and Trademark Office to FDA CDER,Other,Application,2020-10-02T04:00:00Z,2020,10,2020-10-02T04:00:00Z,,2020-10-02T21:46:19Z,,0,0,09000064848b8f82